|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
10 months to Dec 31, 2021
|
|
|---|---|---|---|
| Operating and formation costs | |||
| Loss from operations | |||
| Expensed offering costs | |||
| Expensed offering costs | |||
| Change in fair value of warrant liabilities | |||
| Change in fair value of convertible promissory notes | |||
| Change in fair value of derivative liability - promissory note - related party redemption feature | |||
| Gain on investments held in Trust Account | |||
| Gain on waiver of deferred underwriting fees | |||
| Interest income | |||
| Interest expense | |||
| Net income | |||
| Basic and diluted weighted average shares outstanding, Class A ordinary shares | |||
| Basic and diluted net income per share, Class A ordinary shares | |||
| Basic and diluted weighted average shares outstanding, Class B ordinary shares | |||
| Basic and diluted net income per share, Class B ordinary shares |
Loading...